Xofluza (baloxavir marboxil) is indicated for the treatment acute uncomplicated influenza in patients 12 years of age and older who have been symptomatic for no more than 48 hours.
Approved presentations:
20 mg in packs containing 2 or 4 tablets
40 mg in packs containing 1 or 2 tablets
Please see full prescribing information and available presentations at:
[1] Prescribing Information (FDA): Xofluza (baloxavir marboxil) [PDF], Novartis, October 2018.Please note that this medicine may have also been approved in other regions than the ones we’ve listed. If you have a question about it’s approval in a specific country feel free to contact our support team.
| Quantity | 1 tablet x 40 mg, 10 tablets x 20 mg |
|---|
Be the first to review “Xofluza (baloxavir marboxil)”
Related products
OTHER MEDICATIONS
$2,888.00 – $9,198.00
This product has multiple variants. The options may be chosen on the product page 
OTHER MEDICATIONS
$31,558.00 – $52,597.00
This product has multiple variants. The options may be chosen on the product page 
OTHER MEDICATIONS
$1,383.00 – $4,190.00
This product has multiple variants. The options may be chosen on the product page 
OTHER MEDICATIONS
Biktarvy (bictegravir, emtricitabine, tenofovir alafenamide)
$2,374.00
This product has multiple variants. The options may be chosen on the product page
Reviews
There are no reviews yet.